GlassScriptPhysician profile
Bassem Matta
NPI 1114366515
$2,672.46
in general payments reported to CMS, 2019-2025
14 companies · $896 in 2025
The $896 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $140 · 2022: $194 · 2023: $637 · 2024: $559 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Education: $30.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,061.25 |
| Education | $30.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $900.75 | 2020-2025 | |
| Boston Scientific Corporation | $346.46 | 2019-2024 | Exalt Model D |
| Medtronic, INC. | $341.01 | 2024-2025 | Nexpowder, Endoflip, Dragonfly Pancreaticobiliary Scope and Instrument Channel Caps |
| Olympus America INC. | $323.39 | 2019-2023 | Visiglide, Single Use Electrosurgical Knife Kd-655 |
| Micro-Tech Endoscopy USA, INC. | $241.06 | 2023-2025 | Lesionhunter, Edgehog, Edgehog |
| Olympus Corporation of The Americas | $131.13 | 2019 | |
| Janssen Biotech, INC. | $98.46 | 2024 | Tremfya, Stelara |
| Pfizer INC. | $66.38 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.51 | 2020-2023 | Xifaxan |
| Gilead Sciences, INC. | $48.86 | 2023-2025 | |
| Celltrion USA INC. | $43.82 | 2024-2025 | Vegzelma |
| Celgene Corporation | $30.19 | 2022 | |
| Fresenius Kabi USA, LLC | $24.54 | 2023 | |
| Merck Sharp & Dohme LLC | $16.90 | 2023 | Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassem Matta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.